Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent agony designs and is also present at micromolar stages within the brain soon after systemic injection. Conolidine CONOCB2™ essentially performs by creating a barrier in between the opioid receptors while in the brain as well as the "scavenger" receptors https://sandral337egf7.vblogetin.com/profile